ESALY Stock UPDATES Eisai Co Ltd Spons A (ESALY) 41.5600 08/11/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Eisai Co Ltd Spons A (ESALY) 41.5600 $ESALY

Eisai Supports Earthquake Relief Efforts in Yunnan, China
JCN Newswire - Wed Aug 06, 8:51PM CDT
Eisai expresses its heartfelt sympathies to all those affected by the recent earthquake which occurred in Ludian county of Zhaotong city, Yunnan province, China.

Arena Pharmaceuticals Falls on Wider-than-Expected Q2 Loss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Aug 04, 10:10AM CDT
Arena Pharmaceuticals, Inc. (ARNA) reported a net loss (excluding one-time items) of 12 cents per share in the second quarter of 2014.

EMA Grants Eisai's Anticancer Agent Lenvatinib Request for Accelerated Assessment
JCN Newswire - Wed Jul 30, 9:48PM CDT
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai" announced today that its U.K. subsidiary Eisai Europe Ltd. has been granted an accelerated review by the European Medicines Agency (EMA) for its in-house developed anticancer agent lenvatinib mesylate ("lenvatinib" in the treatment of radioiodine-refractory differentiated thyroid cancer.

Arena Pharmaceuticals-Eisai Boost Obesity Drug Sales Force - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jul 11, 3:45PM CDT
Arena Pharmaceuticals, Inc. (ARNA) announced that partner Eisai Inc. (ESALY) has increased the sales force of Belviq.

Eisai Receives European Commission Approval of Indication Expansion for Anticancer Agent Halaven for Advanced Breast Cancer After Only One Prior Chemotherapy
JCN Newswire - Thu Jul 03, 7:58PM CDT
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai" announced today that it has received approval from the European Commission of the indication expansion of Halaven (generic name: eribulin mesylate, "eribulin" to contribute to earlier treatment of patients with locally advanced or metastatic breast cancer who have progressed after at least one chemotherapeutic regimen for advanced disease. Prior therapy should have included an anthracycline and a taxane in either the adjuvant or metastatic setting, unless patients were not suitable for these treatments.

Eisai to Launch First Chocola BB Brand Product "Chocola BB Royal Drink" in China
JCN Newswire - Wed Jul 02, 5:46AM CDT
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai" announced today that it has launched its Chocola BB Royal Drink in China. This marks the first Chocola BB series product launched in China by Eisai.

Orexigen falls on further FDA delays for diet pill
By The Associated Press - AP - Wed Jun 11, 11:58AM CDT
Shares of Orexigen Therapeutics tumbled more than 16 percent in afternoon trading Wednesday after regulators extended by three months a review of its experimental weight loss treatment.

Does Wall Street Still Hate Arena Pharmaceuticals?
George Budwell, The Motley Fool - Motley Fool - Mon Jun 09, 5:00PM CDT
It's no secret that Wall Street has been betting heavily against Arena Pharmaceuticals ,  both before and after the Food and Drug Administration approved the company's fat-fighting pill, Belviq. The investing thesis is simple and to the point:...

Is Arena or VIVUS the Better Obesity Drug Stock?
Leo Sun, The Motley Fool - Motley Fool - Sat May 31, 12:30PM CDT
Investors had high hopes for Arena 's Belviq and VIVUS ' Qsymia when in 2012 they became the  first new obesity drugs in 13 years to receive FDA approval. Yet by looking at how Arena and VIVUS have...

Does Arena Pharmaceuticals Have An Anti-Smoking Opportunity?
George Budwell, The Motley Fool - Motley Fool - Fri Mar 28, 1:30PM CDT
Drugs that go on to garner the coveted blockbuster status, or $1 billion in annual sales, are often able to do so by being used for multiple indications. This can be achieved through either a formal label expansion process involving clinical trials...

Ironwood Initiates GERD Study, Shares Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 19, 2:25PM CDT
Ironwood Pharmaceuticals announced the initiation of a phase IIa study on its gastroesophageal reflux disease candidate, IW-3718.

Biogen, Eisai Join Up in Alzheimer's Drug Pact
Ben Fidler, The Motley Fool - Motley Fool - Thu Mar 06, 5:30PM CST
Biogen Idec may be best known for its multiple sclerosis drugs, but the biotech giant is also giving itself a few more chances to succeed in the high-risk field of Alzheimer's disease therapies. Cambridge, Mass.-based Biogen today cut a...

Biogen-Eisai Ink Alzheimer's Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 06, 3:45PM CST
Biogen Idec and Eisai announced a development and commercialization agreement for a couple of Alzheimer's disease candidates in Eisai's pipeline.

Today’s Top Biotech Stories: Xoma, Biogen, Agenus, and GSK
Leo Sun, The Motley Fool - Motley Fool - Wed Mar 05, 8:01AM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. Let's take a look at four stocks that could make health care...

Have Anti-Obesity Drug Prospects Finally Gone Belly-Up?
Sean Williams, The Motley Fool - Motley Fool - Tue Mar 04, 1:05PM CST
On paper, it just makes so much sense that physicians and patients would turn to chronic weight control management therapies offered by VIVUS and Arena Pharmaceuticals as in addition to proper diet and exercise to lose weight. But paper is...

Arena Posts Wider Loss, Misses Ests - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 28, 11:20AM CST
Arena Pharmaceuticals reported net loss per share of 11 cents in the fourth quarter of 2013.

Biotech Showdown: Arena Pharmaceuticals vs. VIVUS Inc.
George Budwell, The Motley Fool - Motley Fool - Thu Feb 20, 8:59AM CST
The obesity-drug space is turning out to be tough sledding for Arena Pharmaceuticals and VIVUS , with both of their respective FDA approved medications failing to meet market expectations in terms of prescription numbers. As a result, shares of...

Arena Pharmarceuticals and Chelsea Therapeutics International Ltd Could Be Today's Biggest Movers in
George Budwell, The Motley Fool - Motley Fool - Fri Feb 14, 8:15AM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. Good morning, fellow Foolish investors! It's time to check in...

Eisai Announces Launch of Pariet(R) Triple Formulation Combination Packs Rabecure(R) 400 and 800 and Rabefine(R), for Primary and Secondary H.Pyloei Eradication Respectively, in Japan
JCN Newswire - Wed Feb 12, 11:09PM CST
Eisai Co., Ltd. announced today that it will launch two types of triple formulation combination packs that contain its proton pump inhibitor Pariet(R) (rabeprazole sodium) in Japan on February 14 for use in Helicobacter pylori eradication.

Can These Obesity Drug Stocks Bounce Back in 2014?
Leo Sun, The Motley Fool - Motley Fool - Wed Feb 12, 1:34PM CST
Here's some good news -- America isn't the most obese nation in the world. The bad news is that America still ranks second behind Mexico, according to a United Nations report last July. About 31.8% of American adults are still classified as...




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Endava's Audit Scandal: Investors Face Crucial Decision

Updated Category News Views 14

Endava's Unexpected Crisis: What's Happening? It's the kind of mess no investor wants to wake up to: on October 28, 2026, Endava plc (NYSE: DAVA) laid out a smorgasbord of screw-ups that have left the market reeling. The company's last few days were a whirlwind, featuring the CFO's abrupt exit and the CEO swap. This shake-up didn't happen in isolation—the announcement...

Continue Reading
Fluence Energy Faces Heat: Class Action Lawsuit Unfolds

Updated Category News Views 25

Fluence Energy's Difficult Waters Investors in Fluence Energy (NASDAQ: FLNC) are having a moment of reckoning, no doubt. November 2nd saw a nearly 9% drop in FLNC stock, further fueled by the sudden departures of the CEO and CFO just days earlier. This marks a bitter chapter for Fluence as its stock continues to bleed, leaving many wondering what seismic shifts are yet to...

Continue Reading
FFR's Michigan Milestone and Major Robotics Update

Updated Category News Views 193

Nobody's going to argue that breaking into new territories isn't a gamble, but sometimes you just need to roll the dice. FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) is banking on their move with Aegis Ultra robots, making an academic splash at Central Michigan University. This isn't just about ticking off another state; it's about stacking the deck with new...

Continue Reading
Salvation Army’s Angel Tree: 2026 Holiday Cheer Drive

Updated Category News Views 9

Kickstarting Holiday Generosity: The Angel Tree Program Man, there's something heartwarming about a Christmas that shines bright for everyone. The Salvation Army's Angel Tree program is back for another season, rolling up with a mission to spark joy across the country. For over 45 years now, this initiative's been the answer to many Christmas wish lists, especially for...

Continue Reading
Veritran's Bold Move: Acquiring PrismaCampaigns Inc.

Updated Category News Views 58

Veritran's Strategic Leap Forward They're not messing around, folks. Veritran just made a power move by acquiring 100% of PrismaCampaigns Inc., and it’s more than just another day in the office. This marks a pivotal expansion of their American footprint, and they're zeroing in on our banks and credit unions with laser precision. Why This Matters for Financial...

Continue Reading
Scientific Games Joins NCPG’s 2026 Campaign Again

Updated Category News Views 74

Scientific Games Backs Responsible Gaming Again It's another year, and here's Scientific Games once more, guns blazing for a cause that's needed more than a few times over—responsible gambling. Those folks got their hearts in the right place, joining the National Council on Problem Gambling's 2026 Gift Responsibly campaign. Ninth time running, no less! It's like...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 117

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading
Cinmoore's Smart Camera: A Game Changer for Car Security

Updated Category News Views 32

Pioneering Car Security with Cinmoore's Smart Camera Ever left your car in the parking lot, heart pounding, wondering if it's safe while you run errands? Well, Cinmoore might just quell that parking paranoia with their new gizmo, the Smart Parking Camera DC1U. This device isn't just some fancily-packaged disappointment—it promises some serious peace of mind for those...

Continue Reading
Ballard's Q3 2026: Navigating Losses and Bold Moves

Updated Category News Views 80

Ballard’s Financial Puzzles in Q3 2026 Riding the rough waters of the third quarter in 2026, Ballard Power Systems set out its stall with some eyebrow-raising numbers. This ain't the bustling diner vibe we normally see for a thriving business. The results paint a cautious picture sprinkled with strategic shifts that demand a keen eye. GeoPura Acquisition: A Strategic...

Continue Reading
Baidu's Q3 2026: AI Explodes Amid Marketing Slump

Updated Category News Views 35

Baidu Looks to AI as Revenue Driver in Q3 2026 You know, Baidu's got one heck of a story this quarter. Despite some clouds hanging over them, they’ve managed to find a silver lining in their AI ventures. It’s like they’ve got this magic bullet with AI Cloud growth skyrocketing 94% year over year. That’s not just a rabbit outta the hat; it’s more like pulling a...

Continue Reading

Top 5 Most Recently Viewed Articles

Projected Growth of the Fast Food Sector through 2029

Updated Category News Views 169

Overview of Fast Food Market Growth The fast food industry is on the cusp of significant transformation, projected to grow by USD 119.6 billion between the years 2025 and 2029. This remarkable growth is anticipated to occur at a compounded annual growth rate (CAGR) of 3%. Companies in the fast food sector are increasingly recognizing the need to enhance their online...

Continue Reading
Clean Cooking Accelerator: Africa's Energy Gamble Unveiled

Updated Category News Views 200

Feb 18, 2026, saw a significant move during the International Energy Agency's Ministerial as the Clean Cooking Accelerator Initiative was unveiled. Launched by powerhouses like The Rockefeller Foundation and Global Energy Alliance, this initiative is aiming for a seismic shift in how nearly one billion Africans cook daily—traditionally relying on wood and charcoal....

Continue Reading
Volta Finance Limited: Monthly Insights and Performance Metrics

Updated Category News Views 252

Understanding Volta Finance Limited's Performance for September 2025 Volta Finance Limited (VTA / VTAS) recently released its monthly report for September 2025. This report sheds light on the performance metrics that have shaped the company's strategies and outcomes over the past month, illustrating how they navigate an ever-changing financial landscape. Performance...

Continue Reading
AutoFull's Massage Gaming Chair Powers Esports

Updated Category News Views 36

Innovation Meets Gaming at IEM Cologne 2026 Nobody expected gaming chairs to steal the spotlight at the IEM Cologne Major 2026, but AutoFull had other plans. By rolling out their blazing new pieces of gaming tech, they're not just a sponsor — they're part of the competitive edge. Setting the Stage at a Competitive Colosseum Team FALCONS may have walked away with the...

Continue Reading
IBM's Nickle LaMoreaux Earns Prestigious HR Executive Title

Updated Category News Views 114

Nickle LaMoreaux Recognized as 2024 HR Executive of the Year WEST PALM BEACH, Fla. and BOSTON - In a significant announcement from HR Executive™, Nickle LaMoreaux, serving as Senior Vice President and Chief Human Resources Officer at IBM, has been honored as the 2024 HR Executive of the Year. This distinguished recognition reflects her exceptional contributions to the...

Continue Reading